Akebia Therapeutics, Inc.

Contributing Author

Recent Articles by Akebia Therapeutics, Inc.

Aug-07	Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights AKBA GlobeNewswire
Aug-06	Akebia Therapeutics to Present at Canaccord Genuity's 45th Annual Growth Conference AKBA GlobeNewswire
Aug-04	Akebia Initiates Vafseo (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization AKBA GlobeNewswire
Aug-01	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Jul-31	Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire
Jul-08	Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference AKBA GlobeNewswire
Jul-01	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Jun-04	Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology AKBA GlobeNewswire
Jun-02	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-28	Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025 AKBA GlobeNewswire
May-27	Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025 AKBA GlobeNewswire
May-13	Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference AKBA GlobeNewswire
May-08	Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights AKBA GlobeNewswire
May-01	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-01	Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.